BNR
Burning Rock Biotech LimitedNASDAQHealthcare$16.20+0.62%ClosedMarket Cap: $17.4M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.22
P/S
0.22
EV/EBITDA
12.13
DCF Value
$-596.21
FCF Yield
-31.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
74.7%
Operating Margin
-10.2%
Net Margin
-10.3%
ROE
-9.9%
ROA
-6.7%
ROIC
-9.3%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $124.6M | 78.0% | $-11.9M | $-15.2M | $-14.70 | — |
| FY 2025 | $524.9M | 74.7% | $-53.4M | $-53.8M | $-49.60 | — |
| Q3 2025 | $131.6M | 75.1% | $-16.1M | $-16.8M | $-15.60 | — |
| Q2 2025 | $148.6M | 72.8% | $-11.5M | $-9.7M | $-9.00 | — |
| Q1 2025 | $133.1M | 73.2% | $-15.2M | $-13.5M | $-12.50 | — |
| Q4 2024 | $126.0M | 71.0% | $-81.9M | $-81.3M | $-78.70 | — |
| FY 2024 | $515.8M | 70.3% | $-357.6M | $-346.6M | $-33.67 | — |
| Q3 2024 | $128.6M | 71.4% | $-38.6M | $-35.7M | $-34.60 | — |
| Q2 2024 | $135.5M | 70.4% | $-111.2M | $-108.0M | $-105.30 | — |
| Q1 2024 | $125.6M | 68.2% | $-125.8M | $-121.5M | $-118.50 | — |
| Q4 2023 | $121.1M | 64.5% | $-166.3M | $-162.2M | $-158.40 | — |
| FY 2023 | $537.4M | 67.6% | $-669.3M | $-653.7M | $-63.84 | — |